Precision risk-based screening might maximize benefit and minimize harm

Precision risk-based screening might maximize benefit and minimize harmPrecision risk-based screening might maximize benefit and minimize harm, Published online: 14 September 2018; doi:10.1038/s41571-018-0093-0Population-based mammographic screening is widely accepted as an intervention to reduce overall mortality from breast cancer, but at the cost of morbidity due to false positives and substantial overdiagnosis and overtreatment of ultra-low-risk disease, as well as personal and health-economic burdens. Recent data from a modelling study strengthen the rationale for personalized, risk-based screening approaches, now being tested in multiple clinical trials.
Source: Nature Clinical Practice Oncology - Category: Cancer & Oncology Authors: Source Type: research